Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma : a clinical, haematological and biological studyCAIRO, Mitchell S; DAVENPORT, Virginia; REAMAN, Gregory H et al.British journal of haematology. 2005, Vol 128, Num 1, pp 49-58, issn 0007-1048, 10 p.Article

Ototoxicity in Children With High-Risk Neuroblastoma: Prevalence, Risk Factors, and Concordance of Grading Scales—A Report From the Children's Oncology GroupLANDIER, Wendy; KNIGHT, Kristin; GURNEY, James G et al.Journal of clinical oncology. 2014, Vol 32, Num 6, pp 527-534, issn 0732-183X, 8 p.Article

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic NeuroblastomaASGHARZADEH, Shahab; SALO, Jill A; WAKAMATSU, Peter et al.Journal of clinical oncology. 2012, Vol 30, Num 28, pp 3525-3532, issn 0732-183X, 8 p.Article

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for NeuroblastomaYU, Alice L; GILMAN, Andrew L; SHIMADA, Hiro et al.The New England journal of medicine. 2010, Vol 363, Num 14, pp 1324-1334, issn 0028-4793, 11 p.Article

A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic supportPRADHAN, Kamnesh R; JOHNSON, Cynthia S; VIK, Terry A et al.Pediatric blood & cancer. 2006, Vol 46, Num 7, pp 793-802, issn 1545-5009, 10 p.Article